Compare ETFs and analyze holdings overlap
Search and add ETFs. Minimum 2 for comparison.
| ETF | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception |
|---|---|---|---|---|---|---|---|---|---|
| BKCC | 0.69% | 11.46% | 24.28% | 23.46% | 46.94% | 22.92% | 12.38% | 10.16% | 7.99% (May 2011) |
| MEDX | 1.27% | 10.72% | 0.68% | 2.60% | 16.46% | — | — | — | 10.91% (Apr 2025) |
Last six full-calendar years
| ETF | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| BKCC | 28.02% | 17.17% | 5.27% | -14.28% | 28.28% | -2.93% |
| MEDX | 10.98% | — | — | — | — | — |
TWR = Time-Weighted Return (measures fund performance). MWRR = Money-Weighted Return (measures your personal return including contribution timing). Past performance does not guarantee future results.
Latest reported top holdings for each ETF
| # | Holding | Weight |
|---|---|---|
| 1 | Royal Bank of Canada | 17.35% |
| 2 | Bank of Montreal | 17.0% |
| 3 | Toronto-Dominion Bank | 16.94% |
| 4 | Bank of Nova Scotia | 16.48% |
| 5 | Canadian Imperial Bank of Commerce | 16.07% |
| 6 | National Bank of Canada | 16.02% |
| 7 | CASH | 0.49% |
| 8 | Market value of options | -0.34% |
| # | Holding | Weight |
|---|---|---|
| 1 | Thermo Fisher Scientific Inc | 5.7% |
| 2 | Novo Nordisk A/S - ADR | 5.62% |
| 3 | Abbott Laboratories | 5.42% |
| 4 | Stryker Corp | 5.32% |
| 5 | Abbvie Inc | 5.3% |
| 6 | Bristol-Myers Squibb Co | 5.29% |
| 7 | Amgen Inc | 5.18% |
| 8 | Johnson & Johnson | 5.14% |
| 9 | Vertex Pharmaceuticals Inc | 5.03% |
| 10 | Merck & Co Inc | 5.02% |
Our in-depth Canadian investing course covers ETFs, TFSAs, RRSPs, and building a portfolio you can stick with.